The Assessment of Movement Disorders Utilizing Live Two-Way Video
The purpose of this project is to determine the equivalency of extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) examinations conducted via live two-way video versus live examinations completed in-person
|Study Design:||Observational Model: Case-Only
Time Perspective: Cross-Sectional
|Official Title:||The Assessment of Movement Disorders Utilizing Live Two-Way Video|
- Abnormal Involuntary Movement Scale (AIMS) when done in-person versus via two-way video [ Time Frame: Baseline ] [ Designated as safety issue: No ]
- Modified Simpson Angus Scale (mSAS) short version when done in-person versus via two-way video [ Time Frame: Baseline ] [ Designated as safety issue: No ]
- the correlation between the short version and full version of the Modified Simpson Angus Scale (mSAS) [ Time Frame: Baseline ] [ Designated as safety issue: No ]total score of short version-Modified Simpson Angus Scale vs. total score of full version-Modified Simpson Angus Scale
|Study Start Date:||November 2011|
|Estimated Study Completion Date:||June 2013|
|Estimated Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|
Inclusion Criteria: Inpatients and outpatients aged 18-75 years old who have been taking antipsychotics for longer than 6 months in their life time, and that have been compliant for the past week. Patients will be referred by their treating doctors if they have some evidence of movement disorder based on the physician's clinical judgment. We will also include 25% of the sample without any evidence of movement disorder.
Exclusion Criteria: Patients who have medical conditions which make it difficult to perform a physical examination. Patients who are clinically too ill to consent and/or unable to cooperate with the examination procedures.
Other: Two way video assessment
Participants will be assessed extrapyramidal symptoms and tardive dyskinesia
Extrapyramidal symptoms (EPS) and tardive dyskinesia (TD) are one of the most frequent and troublesome adverse events when taking antipsychotic agents. The investigators aim in this study to determine if the investigators can conduct examinations for EPS and TD remotely using live two-way video. It is potentially beneficial for patients, especially those who are located far away from psychiatrists if they could be seen by trained clinicians and assessed for EPS and TD via two-way video in the future. Participants will be asked to have a medical assessment which consists of simple questions and some examination of their movements via two-way video and in person. The investigators will compare the results of video examinations with the results of live examinations.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01467089
|Contact: Taishiro Kishimoto, MD/PhD||718-470-8386||Tkishimoto@nshs.edu|
|United States, New York|
|The Zucker Hillside Hospital||Recruiting|
|Glen Oaks, New York, United States, 11004|
|Contact: Taishiro Kishimoto, MD 718-470-8386 firstname.lastname@example.org|
|Principal Investigator:||Tashiro Kishimoto, MD/PhD||North Shore Long Island Jewish Health System|